ArticleCancer biology & medicine2021

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.

Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.